Lung Cancer Target Selector Assay Featured at World Conference on Lung Cancer
Clinical data show the utility of Biocept’s liquid biopsy assay in therapeutic management of patients with non-small cell lung cancer.
Read MorePosted by Steve Halasey | Sep 28, 2015 | Research |
Clinical data show the utility of Biocept’s liquid biopsy assay in therapeutic management of patients with non-small cell lung cancer.
Read MorePosted by Steve Halasey | Sep 22, 2015 | Molecular Diagnostics, Research |
Study highlights the speed and reliability of a new sample protocol for biomarker development.
Read MorePosted by Elaine Sanchez Wilson | Aug 30, 2015 | Cancer, Molecular Diagnostics |
An indispensable component of personalized medicine, companion diagnostics are certain to increase in the breadth of their application to disease areas.
Read MorePosted by Steve Halasey | Aug 11, 2015 | Research |
Working with a global collaboration of stakeholders in personalized cancer medicine, HTG’s platform will contribute to the development of gene expression molecular profiling tests for multiple targeted therapies.
Read MorePosted by Steve Halasey | Jul 14, 2015 | Research |
A study led by Mayo Clinic researchers has identified a common epigenomic fingerprint and potential target for metastatic cancer therapies.
Read More